Liquid Biopsy Technology Market

The global Liquid Biopsy Technology market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Liquid biopsy technology is a non-invasive diagnostic approach that involves the analysis of biomarkers and genetic material (such as circulating tumor DNA or ctDNA) present in body fluids, primarily blood, to detect and monitor various diseases, especially cancer. Unlike traditional biopsies that involve invasive procedures to collect tissue samples, liquid biopsy offers a less invasive and potentially more convenient method for disease detection and monitoring.
The global market for liquid biopsy technology has been experiencing substantial growth in recent years, driven by the increasing prevalence of cancer and other chronic diseases, the demand for non-invasive diagnostic methods, and advancements in genomic research and personalized medicine. The demand for liquid biopsy technology varies across different regions, with key markets located in North America, Europe, Asia-Pacific, and other regions with a high burden of cancer and robust research infrastructure. North America, including the United States and Canada, has been a dominant market for liquid biopsy technology due to the presence of well-established healthcare systems, high incidence of cancer, and strong investment in medical research. The global market for liquid biopsy technology is expected to continue growing in the coming years, driven by ongoing advancements in genomic research, increasing adoption of personalized medicine, and the need for non-invasive diagnostic solutions.
We have surveyed the Liquid Biopsy Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
Liquid Biopsy Technology Market aims to provide a comprehensive presentation of the global market for Liquid Biopsy Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy Technology. Liquid Biopsy Technology Market contains market size and forecasts of Liquid Biopsy Technology in global, including the following market information:
Global Liquid Biopsy Technology market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Liquid Biopsy Technology companies in 2024 (%)
Total Market by Segment:
Global Liquid Biopsy Technology market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Liquid Biopsy Technology market segment percentages, by Type, 2024 (%)
CTCs
ctDNA
Exosomes
Global Liquid Biopsy Technology market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Liquid Biopsy Technology market segment percentages, by Application, 2024 (%)
Blood Sample
Urine Sample
Other Bio Fluids
Global Liquid Biopsy Technology market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Liquid Biopsy Technology market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liquid Biopsy Technology revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Liquid Biopsy Technology revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Exact Sciences
Guardant Health
Natera
Bio-Techne
LabCorp
Endress+Hauser
MDxHealth
MutantDx
Thermo Fisher Scientific
Norgen Biotek
Nucleix
OraSure Technologies
Qiagen
Bio-Rad Laboratories
Biocartis
NeoGenomics
Sysmex Inostics
Menarini Silicon Biosystems
Biocept
ANGLE plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liquid Biopsy Technology, market overview.
Chapter 2: Global Liquid Biopsy Technology market size in revenue.
Chapter 3: Detailed analysis of Liquid Biopsy Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liquid Biopsy Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.